Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer. uri icon

authors

  • Yuan, Yuan
  • Tang, Aileen
  • Martinez, Norma
  • Patel, Niki Dipesh
  • Mina S. Sedrak, MD, MS
  • Waisman, James
  • Li, Daneng
  • Sanani, Shamel
  • Presant, Cary A
  • Mortimer, Joanne
  • Lee, Jin Sun
  • Yost, Susan E
  • Stiller, Tracey
  • Blanchard, M Suzette
  • Padam, Simran
  • Katheria, Vani
  • Kim, Heeyoung
  • Sun, Canlan

publication date

  • January 1, 2021